VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA

被引：0
|
作者：
Subramaniam, Bavani [1 ]
Roy, Debasish [1 ]
Woldegerima, Ayda [1 ]
Przystal, Justyna [2 ]
Zhang, Jie [3 ]
Laternser, Sandra [2 ]
Kritzer, Bettina [2 ]
Yadavilli, Sridevi [1 ]
Mueller, Sabine [2 ,3 ]
Packer, Roger [1 ,4 ]
Nazarian, Javad [1 ,2 ]
机构：
[1] Childrens Natl Hosp, Ctr Genet Med Res, Washington, DC USA
[2] Univ Childrens Hosp Zurich, Childrens Res Ctr, Dept Oncol, Zurich, Switzerland
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Childrens Natl Hosp, Gilbert Family Neurofibromatosis Inst, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2024年 / 26卷
关键词：
D O I：
10.1093/neuonc/noae064.091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-38
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dianhydrogalactitol (VAL-083) in combination with AZD1775 increases survival in diffuse intrinsic pontine glioma (DIPG), in vivo
    Steino, Anne
    Yang, Xiaodong
    Kline, Cassie
    Bacha, Jeffrey
    Brown, Dennis M.
    Mueller, Sabine
    CANCER RESEARCH, 2019, 79 (13)
  • [2] DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO
    Steino, Anne
    Yang, Xiaodong
    Kline, Cassie
    Brown, Dennis
    Bacha, Jeff
    Liu, Lei
    Mueller, Sabine
    NEURO-ONCOLOGY, 2019, 21 : 77 - 77
  • [3] PRECLINICAL STUDIES OF DIANHYDROGALACTITOL (VAL-083) IN DIPG, AS SINGLE AGENT OR AS A COMBINATION WITH RADIATION OR AZD1775
    Steino, Anne
    Bacha, Jeffrey
    Brown, Dennis
    Mueller, Sabine
    NEURO-ONCOLOGY, 2018, 20 : 60 - 60
  • [4] RELA fusion-positive ependymoma and diffuse midline glioma treated with VAL-083 under expanded access - case reports
    Kamiya-Matsuoka, Carlos
    Knight, Stephanie
    Hanna, Teresa
    Gregory, Timothy A.
    Langlands, John
    Brown, Dennis
    Puduvalli, Vinay K.
    CANCER RESEARCH, 2023, 83 (08)
  • [5] DIANHYDROGALACTITOL (VAL-083) HAS THE POTENTIAL TO OVERCOME MAJOR CHALLENGES IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Steino, Anne
    Zhai, BeiBei
    Yang, Xiaodong
    Kline, Cassie
    Bacha, Jeffrey
    Brown, Dennis
    Daugaard, Mads
    Mueller, Sabine
    NEURO-ONCOLOGY, 2018, 20 : 86 - 86
  • [6] Molecular mechanisms of dianhydrogalactitol (VAL-083) in cancer treatment
    Zhai, Beibei
    Steino, Anne
    Bacha, Jeffrey
    Brown, Dennis
    Daugaard, Mads
    CANCER RESEARCH, 2016, 76
  • [7] PHASE I/II STUDY OF VAL-083 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
    Shih, Kent C.
    Bacha, Jeffrey
    Brown, Dennis M.
    Garner, William J.
    Schwartz, Richard
    Burris, Howard A., III
    NEURO-ONCOLOGY, 2012, 14 : 104 - 104
  • [8] RELA FUSION-POSITIVE EPENDYMOMA, DIFFUSE MIDLINE GLIOMA AND GRADE 4 IDH MUTANT ASTROCYTOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: CASE REPORTS
    Kamiya-Matsuoka, Carlos
    Weathers, Shaio-Pei
    Knight, Stephanie
    Hanna, Teresa
    Langlands, John
    Brown, Dennis
    Puduvalli, Vinay
    NEURO-ONCOLOGY, 2024, 26
  • [9] Dissecting the molecular mechanism of dianhydrogalactitol (VAL-083) activity in cancer treatment
    Zhai, Beibei
    Steino, Anne
    Bacha, Jeffrey
    Brown, Dennis
    Daugaard, Mads
    MOLECULAR CANCER RESEARCH, 2017, 15
  • [10] Dianhydrogalactitol (VAL-083) has the potential to overcome major challenges in the treatment of DIPG
    Steino, Anne
    Zhai, Beibei
    Bacha, Jeffrey
    Brown, Dennis
    Fouse, Shaun
    Costello, Joe
    Daugaard, Mads
    Mueller, Sabine
    CANCER RESEARCH, 2018, 78 (19)
12345